Two-dose vaccination for shingles is associated with a greater reduction in COVID-19 hospitalizations An association was also found between the shingles vaccine and a 32% lower rate for COVID-19 related hospitalization. One dose of the shingles vaccine correlated with a 16% reduced risk of a COVID-19 diagnosis. As a result, there were 13,028 COVID-19 cases, and 2,765 individuals required hospitalization for severe COVID-19 infection.Īn additional analysis further confirmed lower incidences of COVID-19 and COVID-19 related hospitalization in vaccinated versus unvaccinated individuals. Individuals not vaccinated with at least one shingles vaccine dose reported more COVID-19 diagnoses. Of the approximate 150,000 vaccinated individuals, there were 5,951 COVID-19 diagnoses and 1,066 COVID-19 related hospitalizations. Study results provide strong evidence for association of genetic markers to long COVID mappable to fatigue.25% of COVID-19 patients have lasting reduction in lung function.Can the gut microbiota and metabolome explain variation in anti-SARS-CoV-2 vaccination responses in immunosuppressed IBD patients?.Vaccinated individuals were more likely to have frequent outpatient medical visits before the pandemic and were associated with hypertension and having other vaccinations. There were 57.8% of female participants, with over half describing themselves as non-Hispanic White. About 16.2% of individuals were 50 to 59 years old, and 12.8% were over 80. A control group consisted of 298,488 unvaccinated individuals for comparison. Demographic information of vaccinated versus unvaccinated individualsĪbout 149,244 people were vaccinated with at least one dose of the recombinant adjuvanted zoster vaccine. The COVID-19 vaccines continue to be the best form of protection against SARS-CoV-2. In addition, innate immunity may help weaken severe acute respiratory syndrome coronavirus 2’s (SARS-CoV-2) ability to replicate during early infection.Īlternatively, people who are vaccinated for shingles may already be health-conscious and more proactive in getting vaccinated. The researchers suggest the shingles vaccine may boost innate immunity - increasing the body’s cytokine levels and prepping an antiviral response against potential infections. The study results are correlational, and more research is needed to identify whether it is the shingles vaccine itself or other factors driving the lowered risk of COVID-19. Image Credit: MedstockPhotos / Shutterstock Study: Recombinant adjuvanted zoster vaccine and reduced risk of COVID-19 diagnosis and hospitalization in older adults.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |